Dashboard
Manage Tickers

BVS Bioventus Inc.

Nasdaq bioventus.com


$ 6.67 $ -0.22 (-3.2 %)    

Friday, 17-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 6.66
$ 6.84
$ 6.54 x 70
$ 7.10 x 800
$ 6.66 - $ 6.89
$ 5.81 - $ 14.38
181,542
na
550.64M
$ 0.80
$ 297.32
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-28-2025 10-Q
2 05-06-2025 03-29-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-05-2024 09-28-2024 10-Q
5 08-06-2024 06-29-2024 10-Q
6 05-07-2024 03-30-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 07-01-2023 10-Q
10 05-16-2023 04-01-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-21-2022 10-01-2022 10-Q
13 08-12-2022 07-02-2022 10-Q
14 05-11-2022 04-02-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-10-2021 10-02-2021 10-Q
17 08-11-2021 07-03-2021 10-Q
18 05-13-2021 04-03-2021 10-Q
19 03-26-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bioventus-affirms-fy2025-adj-eps-guidance-of-064-068-vs-071-est-affirms-fy2025-sales-guidance-of-560000m-570000m-vs-565200m-est
Bioventus Affirms FY2025 Adj EPS Guidance ...
08/06/2025 11:05:00

2025 Financial Guidance:Bioventus reiterated its 2025 Financial Guidance provided on May 6, 2025, including an estimated impact...

bioventus-q2-adj-eps-021-inline-sales-147660m-beat-146284m-estimate
Bioventus Q2 Adj. EPS $0.21, Inline, Sales...
08/06/2025 11:03:23

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 31.25...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

the-fda-grants-510k-clearances-for-bioventus-talismann-and-stimtrial-expanding-the-companys-portfolio-of-peripheral-nerve-stimulation-solutions-for-chronic-pain-management
The FDA Grants 510(k) Clearances For Biove...
07/30/2025 11:36:36

These two clearances mark an important step forward for Bioventus and represent a substantial growth opportunity as the Company...

cantor-fitzgerald-initiates-coverage-on-bioventus-with-overweight-rating-announces-price-target-of-12
Cantor Fitzgerald Initiates Coverage On Bi...
07/07/2025 20:25:13

Cantor Fitzgerald analyst Ross Osborn initiates coverage on Bioventus (NASDAQ:BVS) with a Overweight rating and announces Pr...

bioventus-affirms-fy2025-adj-eps-guidance-of-064-068-vs-066-est-affirms-fy2025-sales-guidance-of-56000m-57000m-vs-56487m-est
Bioventus Affirms FY2025 Adj EPS Guidance ...
05/06/2025 11:32:16

Bioventus (NASDAQ:BVS) affirms FY2025 Adj EPS guidance from $0.64-$0.68 to $0.64-$0.68 vs $0.66 analyst estimate. Affirms FY202...

bioventus-q1-adj-eps-008-beats-002-estimate-sales-12388m-beat-12270m-estimate
Bioventus Q1 Adj. EPS $0.08 Beats $0.02 Es...
05/06/2025 11:31:20

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.02 by 300...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

examining-the-future-bioventuss-earnings-outlook
Examining the Future: Bioventus's Earnings...
05/05/2025 18:02:00

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/07/2025 12:08:52

canaccord-genuity-maintains-buy-on-bioventus-maintains-15-price-target
Canaccord Genuity Maintains Buy on Biovent...
03/17/2025 15:31:18

Canaccord Genuity analyst Caitlin Cronin maintains Bioventus (NASDAQ:BVS) with a Buy and maintains $15 price target.

medical-device-firm-bioventus-stock-jumps-on-upbeat-2025-outlook-cuts-debt-by-48-million
Medical Device Firm Bioventus Stock Jumps ...
03/11/2025 15:17:40

Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M a...

korn-ferry-posts-better-than-expected-earnings-joins-bioventus-endeavour-silver-vail-resorts-and-other-big-stocks-moving-higher-on-tuesday
Korn Ferry Posts Better-Than-Expected Earn...
03/11/2025 14:13:32

bioventus-expects-2025-sales-of-560m-570m-versus-consensus-of-55462m-with-adjusted-eps-of-064-to-068-versus-consensus-of-055
Bioventus Expects 2025 Sales Of $560M-$570...
03/11/2025 11:38:48

Bioventus introduced its financial guidance for full-year 2025. The Company expects:Net sales of $560 million to $570 million. ...

bioventus-q4-2024-adj-eps-015-beats-008-estimate-sales-15364m-beat-14517m-estimate
Bioventus Q4 2024 Adj EPS $0.15 Beats $0.0...
03/11/2025 11:35:51

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.08 by 87....

earnings-scheduled-for-march-11-2025
Earnings Scheduled For March 11, 2025
03/11/2025 08:32:14

bioventus-shares-are-trading-higher-after-jp-morgan-upgraded-the-stock-from-underweight-to-neutral-and-raised-its-price-target-from-12-to-13
Bioventus shares are trading higher after ...
12/17/2024 13:56:07

jp-morgan-upgrades-bioventus-to-neutral-raises-price-target-to-13
JP Morgan Upgrades Bioventus to Neutral, R...
12/17/2024 12:16:58

JP Morgan analyst Robbie Marcus upgrades Bioventus (NASDAQ:BVS) from Underweight to Neutral and raises the price target from...

canaccord-genuity-maintains-buy-on-bioventus-raises-price-target-to-15
Canaccord Genuity Maintains Buy on Biovent...
11/06/2024 17:49:40

Canaccord Genuity analyst William Plovanic maintains Bioventus (NASDAQ:BVS) with a Buy and raises the price target from $12 ...

dow-jumps-400-points-yum-brands-posts-downbeat-earnings
Dow Jumps 400 Points; Yum! Brands Posts Do...
11/05/2024 19:32:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION